BridgeBio Pharma, Inc 10-Q for FY2022 Q2
BridgeBio Pharma, Inc. (BBIO)
10-Q
2022-08-04
For: 2022-06-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on August 4, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $73.75M
- up 36.5% from $54.02M a year earlier
- Net loss
- $2.56M
- compared with a net loss of $102.07M a year earlier
- Diluted EPS
- -$0.07
- compared with -$0.66 a year earlier